Growing evidence suggests Ct marks severe COVID-19 illness, but with few quantitative assays, lack of standardization across tests, labs shy from routinely reporting this value.
Developers of EKFC equation claim improved accuracy and precision versus others; editorialists contend this finding is not conclusive, call for further study incorporating a full panel of filtration markers in age and ethnically diverse populations.
A guideline-based approach would have missed nearly half of pathogenic germline variants detected in a pan-population model using an 84-gene panel test.
Special report details lab-driven measurements across 7 core areas that monitor institutional efforts and progress in pain and substance abuse disorder management.
Top papers presented early diagnostics for SARS-CoV-2, considered critical collaborations in addressing future pandemics, evaluated tests’ performance.
Top articles considered the merits of widespread SARS-CoV-2 antibody screening, detailed clinical validation of a PCR test, reviewed evidence around lab tests and patient outcomes, and outlined lab risk assessment protocols.
